LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
0.9189
-0.0261 (-2.76%)
At close: Jun 27, 2025, 4:00 PM
0.9100
-0.0089 (-0.97%)
After-hours: Jun 27, 2025, 6:49 PM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $17.53 million as of June 27, 2025. Its market cap has decreased by -89.99% in one year.
Market Cap
17.53M
Enterprise Value
42.20M
1-Year Change
-89.99%
Ranking
Category
Stock Price
0.92
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $17.53M, a decrease of -92.30%. That is a compound annual growth rate of -48.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 17.75M | -73.12% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |